| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027143 |
| Receipt No. | R000031106 |
| Official scientific title of the study | Long-term intake experiment of D-psicose for type 2 diabetic patients |
| Date of disclosure of the study information | 2017/04/26 |
| Last modified on | 2018/10/31 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Long-term intake experiment of D-psicose for type 2 diabetic patients | |
| Title of the study (Brief title) | Long-term intake experiment of D-psicose for type 2 diabetic patients | |
| Region |
|
|
| Condition | ||
| Condition | Type 2 diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Verify the safety of diabetic and cholesterol elevated persons when 5 g of D - psicose is continuously ingested for 12 months. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluate the fluctuation of the value of LDL-C before and after administration of D-psicose |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of the test product for 12 months | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.fasting blood glucose level 126 mg / dL or more or HbA 1 c (NGSP) 6.5% or more
2. LDL-C high price person (LDL-C 120 mg / dL or more and less than 160 mg / dL) 3. Persons who are taking medication for treating diabetes or who are administering insulin |
|||
| Key exclusion criteria | 1.Patients falling under D-psicose administration contraindications
2.Patients taking oral administration of HMG-CoA reductase inhibitor 3.Patients participating in other clinical trials 4.Pregnant women, maternity women, lactating women or women with the possibility of pregnancy 5.Patients who have poor glycemic control with HbA1c> 8% 6.Patients who have severe renal dysfunction (serum creatinine value> 1.5 mg / dl) 7.Patients with other serious complications 8.Other patients judged inappropriate as judged by doctors |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Koji murao |
| Organization | Kagawa University |
| Division name | department of endocrinology and metabolism |
| Address | 1750-1 Ikenobe,Miki-cho,Kita-gun,Kagawa |
| TEL | 087-891-2230 |
| labmed@med.kagawa-u.ac.jp | |
| Public contact | |
| Name of contact person | Koji murao |
| Organization | Kagawa University |
| Division name | department of endocrinology and metabolism |
| Address | 1750-1 Ikenobe,Miki-cho,Kita-gun,Kagawa |
| TEL | 087-891-2230 |
| Homepage URL | |
| labmed@med.kagawa-u.ac.jp | |
| Sponsor | |
| Institute | Kagawa University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Matsutani Chemical Industry Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031106 |